“The thrill of making an impact on human health and well-being keeps me going.”
Leader of the Cloning/Molecular Biology Techniques Team
Biomarkers and Mechanism in Musculoskeletal Diseases
Dr. Ed Purdue is currently Associate Scientist and Director of Osteolysis Research at Hospital for Special Surgery (HSS) in New York, NY, the number 1 ranked orthopedic hospital in the world. His research laboratory focuses both on basic mechanisms of bone cell biology through NIH and DoD funded projects, and also on translational approaches towards improving the lives of patients at risk of implant failure following joint replacement surgery. These research directions combine Dr. Purdue’s background in the cellular and molecular pathogenesis of human disease with the unique clinical infrastructure of the research laboratories at HSS.
The Science Advisory Board’s Food/Beverage Science and Technology Team currently includes 775 Members from around the world. Dr. Salvatore Parisi has been a Science Advisory Board Member since June, 2013, and The Food/Beverage Team Leader since January, 2015.
Dr. Salvatore Parisi, PhD, obtained his MSc in Research Chemistry at the State University of Palermo, Italy, in 1994. After one year of research at the Polytechnic University of Milan, he expanded his activities to the private sector. Dr. Parisi obtained his PhD in ‘Hygiene applied to the Evaluation and Management of Microbiological, Food and Environmental Risks’, at the University of Messina, Italy in 2010. He is an associate of the Sicilian Order of Research Chemists.
- Dr. Mainou received a B.S. degree in Microbiology from Arizona State University in 2002.
- He went on to earn his Ph.D. degree in Microbiology and Immunology from the University of North Carolina at Chapel Hill in 2007.
- He then joined the laboratory of Dr. Terence Dermody in the Division of Pediatrics Infectious Diseases at Vanderbilt University.
- Dr. Mainou now serves as a Research Instructor within the department.
“My research interests are in improving our understanding of host-pathogen interactions to educate the design of improved viral therapeutics.”
Dr. Zhinan Xia is a recognized leader in antibody technologies and therapeutics. He earned his Ph.D. degree in protein engineering from the College of Pharmacy at the University of Kentucky. He also completed an M.S. degree in drug design from the China Pharmaceutical University, Nanjing, China, and a B.S. degree in medicinal chemistry from Nanjing College of Pharmacy, Nanjing, China.
“Recent technological advances suggest a bright future for creating a new generation of antibody-based therapeutics. Our ability to create multi-specific and multi-functional antibodies, along with antibody conjugates and fragments, also provides us with powerful and specific tools to unravel complex biological processes.”
Understanding of the Microbial World
Dr. Sean M. Rollins serves as Assistant Professor at Fitchburg State University, Adjunct Assistant Professor at Massachusetts College of Pharmacy University, and Visiting Microbiology Laboratory Instructor at Harvard Medical School. He has published over 20 peer reviewed research manuscripts in microbiology journals, including PLoS Pathogens, Cellular Microbiology, Molecular Microbiology, and the Journal of Bacteriology.
“Microbiology is so pervasive in our lives that we alter our behavior in response our concern for microbes. We don’t give a lot of thought to many of our daily practices, such as refrigerating and cooking foods, hand washing, and brushing our teeth, but these routines are really a response to microbes in our environment and on our person.”
Dr. Crystal Icenhour: Leader of The Science Advisory Board’s Next-Generation Sequencing Team
Dr. Icenhour earned her Ph.D. in Pathobiology and Molecular Medicine from the University of Cincinnati Medical School of Graduate Studies in 2002. She went on to conduct postdoctoral research in the Thoracic Diseases Research Unit at the Mayo Clinic College of Medicine and in the Department of Infectious Diseases at Duke University Medical Center.